Evidence map›Paper›PMID 30517867›Full record

ArticleCell reports2018

The HDAC-Associated Sin3B Protein Represses DREAM Complex Targets and Cooperates with APC/C to Promote Quiescence.

Anthony J Bainor, Siddharth Saini, Alexander Calderon, Raquel Casado-Polanco, Belén Giner-Ramirez, Claudia Moncada, David J Cantor, Amanda Ernlund, Larisa Litovchick, Gregory David

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities.International journal of molecular sciences · 2025
    Review
  3. SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  4. miR-96-5p expression is sufficient to induce and maintain the senescent cell fate in the absence of stress.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anthony J BainorDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
Siddharth SainiDepartment of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
Alexander CalderonDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
Raquel Casado-PolancoDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
Belén Giner-RamirezDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
Claudia MoncadaDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
David J CantorDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA.
Amanda ErnlundDepartment of Microbiology, NYU Langone Medical Center, New York, NY 10016, USA.
Larisa LitovchickDepartment of Internal Medicine and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
Gregory DavidDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Medical Center, New York, NY 10016, USA; Department of Urology, NYU Langone Medical Center, New York, NY 10016, USA; NYU Cancer Institute, NYU Langone Medical Center, New York, NY 10016, USA. Electronic address: gregory.david@nyumc.org.
NYU Langone Health · USVirginia Commonwealth University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
TRAINING PROGRAM IN MOLECULAR ONCOLOGY &IMMUNOLOGYT32CA009161 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARROLL, WILLIAM L., LEVY, DAVID E · 1985 to 2020
$13.3M
Training in Pharmacological SciencesT32GM066704 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BACH, ERIKA A · 2004 to 2018
$2.6M
Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.R01CA148639 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAVID, GREGORY · 2011 to 2015
$2.0M
DYRK1A signaling in control of cell growth, proliferation and DNA damage repairR01CA188571 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI LITOVCHICK, LARISA · 2015 to 2019
$2.0M
Role of cell cycle withdrawal in restricting pancreatic cancer progression.R21CA155736 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAVID, GREGORY · 2012 to 2014
$590k
(PQ1) Cellular senescence as an initiating event in malignant transformationR21CA206013 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAVID, GREGORY · 2017 to 2018
$373k
The role of Sin3B in normal and malignant hematopoietic stem cell functionsF30CA203047 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CANTOR, DAVID JOHN · 2016 to 2017
$98k
NCI NIH HHS F30 CA203047NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA148639NCI NIH HHS R01 CA188571NCI NIH HHS R21 CA155736NCI NIH HHS R21 CA206013NCI NIH HHS T32 CA009161NIGMS NIH HHS T32 GM007308NIGMS NIH HHS T32 GM066704
6 · The paper itself

Abstract

The mammalian DREAM complex is responsible for the transcriptional repression of hundreds of cell-cycle-related genes in quiescence. How the DREAM complex recruits chromatin-modifying entities to aid in its repression remains unknown. Using unbiased proteomics analysis, we have uncovered a robust association between the chromatin-associated Sin3B protein and the DREAM complex. We have determined that genetic inactivation of Sin3B results in the de-repression of DREAM target genes during quiescence but is insufficient to allow quiescent cells to resume proliferation. However, inactivation of APC/C

Indexed as

Cell CycleAnaphase-Promoting Complex-CyclosomeHistone DeacetylasesHumansMultiprotein ComplexesProtein BindingRepressor ProteinsTranscription, GeneticAnaphase-Promoting Complex-CyclosomeHistone DeacetylasesMultiprotein ComplexesRepressor ProteinsSIN3B protein, humancell cycleDREAME2FquiescenceSin3

Identifiers

PMID30517867
PMCPMC6324198
OpenAlexW2903319426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.